These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2206033)

  • 21. Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia.
    Prisant LM; Downton M; Watkins LO; Schnaper H; Bradford RH; Chremos AN; Langendörfer A
    Am J Cardiol; 1996 Aug; 78(4):420-4. PubMed ID: 8752186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.
    McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M
    Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin: cholesterol-lowering agent.
    DiPalma JR
    Am Fam Physician; 1987 Dec; 36(6):189-92. PubMed ID: 3687679
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
    Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
    Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probucol in hyperlipidemic patients during two years of administration.
    Parsons WB
    Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of lovastatin in primary hypercholesterolemia].
    Nakandakare ER; Garcia RC; Carré JM; Zerbinatti CV; Oliveira HC; Quintão EC
    Arq Bras Cardiol; 1989 May; 52(5):291-5. PubMed ID: 2690785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.
    Goldberg R; La Belle P; Zupkis R; Ronca P
    Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status.
    Kannel WB; D'Agostino RB; Stepanians M; D'Agostino LC
    Am J Cardiol; 1990 Sep; 66(8):1B-10B. PubMed ID: 2206030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of lovastatin in the treatment of primary hypercholesterolemia].
    Chi JM; Li LS; Sun MZ
    Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):32-4, 61. PubMed ID: 1395911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study.
    Tikkanen MJ; Helve E; Jäättelä A; Kaarsalo E; Lehtonen A; Malbecq W; Oksa H; Pääkkönen P; Salmi J; Veharanta T
    Am J Cardiol; 1988 Nov; 62(15):35J-43J. PubMed ID: 3055922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up.
    Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL
    Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group.
    Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia.
    Salel AF; Zelis R; Sodhi HS; Price J; Mason DT
    Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F; Patrone E; Castelluccio A
    Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.